LTTS2021-04-012021-06-30in-bse-fin:OneOperatingExpenses01Member LTTS2021-04-012021-06-30in-bse-fin:OneReportableSegmentRevenue01Member LTTS2021-04-012021-06-30in-bse-fin:OneReportableSegmentRevenue02Member LTTS2021-04-012021-06-30in-bse-fin:OneReportableSegmentRevenue03Member LTTS2021-04-012021-06-30in-bse-fin:OneReportableSegmentRevenue04Member LTTS2021-04-012021-06-30in-bse-fin:OneReportableSegmentRevenue05Member LTTS2021-04-012021-06-30in-bse-fin:OneReportableSegmentResults01Member LTTS2021-04-012021-06-30in-bse-fin:OneReportableSegmentResults02Member LTTS2021-04-012021-06-30in-bse-fin:OneReportableSegmentResults03Member LTTS2021-04-012021-06-30in-bse-fin:OneReportableSegmentResults04Member LTTS2021-04-012021-06-30in-bse-fin:OneReportableSegmentResults05Member LTTS2021-04-012021-06-30in-bse-fin:OneReportableSegmentAssets01Member LTTS2021-04-012021-06-30in-bse-fin:OneReportableSegmentAssets02Member LTTS2021-04-012021-06-30in-bse-fin:OneReportableSegmentAssets03Member LTTS2021-04-012021-06-30in-bse-fin:OneReportableSegmentAssets04Member LTTS2021-04-012021-06-30in-bse-fin:OneReportableSegmentAssets05Member LTTS2021-04-012021-06-30in-bse-fin:OneReportableSegmentLiabilities01Member LTTS2021-06-30in-bse-fin:OneReportableSegmentLiabilities01Member LTTS2021-04-012021-06-30in-bse-fin:OneReportableSegmentLiabilities02Member LTTS2021-06-30in-bse-fin:OneReportableSegmentLiabilities02Member LTTS2021-04-012021-06-30in-bse-fin:OneReportableSegmentLiabilities03Member LTTS2021-06-30in-bse-fin:OneReportableSegmentLiabilities03Member LTTS2021-04-012021-06-30in-bse-fin:OneReportableSegmentLiabilities04Member LTTS2021-06-30in-bse-fin:OneReportableSegmentLiabilities04Member LTTS2021-04-012021-06-30in-bse-fin:OneReportableSegmentLiabilities05Member LTTS2021-06-30in-bse-fin:OneReportableSegmentLiabilities05Member LTTS2021-04-012021-06-30in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss01Member LTTS2021-04-012021-06-30in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss02Member LTTS2021-04-012021-06-30in-bse-fin:OneItemsThatWillBeReclassifiedToProfitAndLoss01Member LTTS2021-04-012021-06-30in-bse-fin:OneItemsThatWillBeReclassifiedToProfitAndLoss02Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares LTTS 2021-04-01 2022-03-31 2021-06-30 INR Millions First quarter Multi segment 2021-04-01 2021-06-30 Unaudited Standalone 13727000000.00 449000000.00 14176000000.00 0.00 0.00 0.00 7737000000.00 98000000.00 461000000.00 3046000000.00 11342000000.00 2834000000.00 0.00 2834000000.00 778000000.00 -30000000.00 748000000.00 0.00 2086000000.00 0.00 0.00 0.00 0.00 2086000000.00 54000000.00 2140000000.00 2140000000.00 0.00 210000000.00 2 19.86 19.73 0.00 0.00 19.86 19.73 Explanatory notes to the statement of standalone unaudited financial results for the quarter ended June 30, 2021 1. The standalone unaudited financial results for the quarter ended June 30, 2021 have been taken on record by the Board of Directors at its meeting held on July 14, 2021. The statutory auditors have carried out limited review of the above standalone unaudited financial results and have issued an unqualified limited review report. The information for the quarter ended June 30, 2021 presented above is extracted from the unaudited interim standalone financial statements. These standalone financial statements are prepared in accordance with the Indian Accounting Standards (Ind-AS) as prescribed under section 133 of the Companies Act, 2013 read with rule 3 of the Companies (Indian Accounting Standards) Rules, 2015, as amended. 2. During the quarter ended June 30, 2021 the Company has allotted 10,979 equity shares of Rs. 2 each fully paid-up on exercise of stock options by employees in accordance with the Company's stock option scheme. 3.The figures for the quarter ended March 31, 2021 are the balancing figures between audited figures in respect of the full financial year ended March 31, 2021 and the limited reviewed year to date figures up to December 31, 2020. 4. Estimation uncertainty relating to COVID-19: The Company has considered internal and certain external sources of information including reliable credit reports, economic forecasts and industry reports up to the date of approval of the financial results in determining the impact on various elements of its financial results. The Company has used the principles of prudence in applying judgments, estimates and assumptions including sensitivity analysis and based on current estimates, the Company expects to fully recover the carrying amount of trade receivables including unbilled receivables, intangible assets and investments. Management of the Company has also reviewed goodwill and is of the opinion that no impairment is required at present. The eventual outcome of impact of the global health pandemic may be different from those estimated as on the date of approval of these financial results. 5. Figures for earlier periods have been regrouped, wherever necessary. Other Expenses 3046000000.00 Industrial Products 2919000000.00 Medical Devices 1761000000.00 Plant Engineering 2342000000.00 Telecom & Hitech 2598000000.00 Transportation 4107000000.00 13727000000.00 13727000000.00 Industrial Products 892000000.00 Medical Devices 548000000.00 Plant Engineering 556000000.00 Telecom & Hitech 351000000.00 Transportation 779000000.00 3126000000.00 98000000.00 194000000.00 Notes for segment information aSegments have been identified in accordance with Indian Accounting Standards ( Ind AS ) 108 on Operating Segments, considering the risk/return profiles of the business, their organisational structure and internal reporting systems. b Property, plant and equipment used and liabilities contracted for performing the Company's business have not been identified to any of the above reported segments as the property, plant and equipment and services are used interchangeably among segments. 2834000000.00 Industrial Products 0.00 Medical Devices 0.00 Plant Engineering 0.00 Telecom & Hitech 0.00 Transportation 0.00 0.00 Industrial Products 0.00 Medical Devices 0.00 Plant Engineering 0.00 Telecom & Hitech 0.00 Transportation 0.00 0.00